found that anti-CD44 blocked the FcγR IgG binding site and thereby inhibited macrophage phagocytosis in an ITP mouse model (73), indicating that anti-CD44 could be a potentially effective alternative to IVIG. Here, FCGR2A is linked to autoimmune thrombocytopenic purpura.